Tissue and Clinical Characterisation of Temporomandibular Joint Diseases
1 other identifier
observational
100
1 country
1
Brief Summary
Temporomandibular joint (TMJ) diseases or dysfunctions affects many patients. Surgical treatment is planned when non-invasive interventions have failed. Still, much is not known regarding aetiology of TMJ diseases and how and why the disease develops over time. The study aims to investigate synovial tissue, synovial fluid and clinical characteristics for patients with TMJ diseases or dysfunctions designated for surgery. Patient samples and clinical variables will be analysed in relation to TMJ diagnosis and related to surgical outcome. The study is a cohort observational study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 14, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 5, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2018
CompletedFirst Submitted
Initial submission to the registry
January 28, 2020
CompletedFirst Posted
Study publicly available on registry
February 5, 2020
CompletedFebruary 5, 2020
January 1, 2020
4.4 years
January 28, 2020
January 30, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Characterisation of synovial tissue
Synovial tissue, harvested during surgery, will be assessed through: common histo-pathology analysis, immunohistochemistry, protein analysis in immunoassays, cell characterisation with flow cytometry, and gene expression profiles with PCR.
1-5 years after study completion
Characterisation of synovial fluid
Synovial fluid, harvested during surgery, will be assessed through: immunoassays, masspectrometry.
1-5 years after study completion
Secondary Outcomes (4)
Comparison of protein content
1-5 years after study completion
Outcome of surgery, change in four different variables
Pre-surgery,6 months after surgery
Factors predicting surgery
Pre-surgery, during surgery
General joint hypermobility
Pre-surgery.
Study Arms (1)
TMJ disease/disorder characterisation
Patients with the diagnosis disc displacement without reduction (DDwoR), or disc displacement with reduction (DDwR), or osteoarthritis (OA), or chronic inflammatory arthritis (CIA) were designated to TMJ surgery. According to the Swedish national guidelines on TMJ surgery DDwoR, OA, and CIA patients had arthroscopy and DDwR had discectomy.
Interventions
Arthroscopic lysis and lavage: performed under general anaesthesia. Before initiation of arthroscopy synovial fluid was sampled with a push-and-pull method. The TMJ was investigated with an arthroscope during irrigation with sterile saline solution. Adhesions were addressed with a coblator. Synovial tissue biopsies were taken from the posterior attachment of the disc. Discectomy without replacement: performed under general anaesthesia. Before initiation of surgery, synovial fluid was sampled as above described. During surgery synovial tissue biopsies were taken as described above.
Eligibility Criteria
Patients referred to the department of Craniofacial Diseases, Karolinska University Hospital, Stockholm, Sweden, because of disc displacement with reduction (DDwR), disc displacement without reduction (DDwoR), osteoarthritis, and chronic inflammatory arthritis (CIA) were eligible for inclusion. Written informed consent were mandatory. Diagnoses were set according to the Diagnostic Criteria for Temporomandibular Disorders accept CIA, where a rheumatologist had to set the diagnosis. Apart from above mentioned diagnoses criteria for surgery were: visual analogue scale (VAS) value of ≥ 4 for TMJ pain or TMJ disability, and DDwoR patients had to have a maximal interincisal opening (MIO) of ≤ 35 mm.
You may qualify if:
- Age 18 or older
- diagnosis DDwoR, DDwR, OA, or CIA
- conservative treatment (i.e. orthotic split, physiotherapy, medication) tried for at least 3-6 months without success
You may not qualify if:
- earlier TMJ surgery
- age under 18 years
- patients not able to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- University of Bergencollaborator
- University of Oslocollaborator
Study Sites (1)
Karolinska Institutet, Department of Dental Medicine
Huddinge, 14104, Sweden
Biospecimen
Synovial tissue: biopsies taken from the superior aspect of the posterior band of the TMJ disc attachment. Synovial fluid: synovial fluid samples will be taken with the push-and-pull method.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bodil Lund, Professor
Karolinska Institutet, University of Bergen
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 28, 2020
First Posted
February 5, 2020
Study Start
January 14, 2014
Primary Completion
June 5, 2018
Study Completion
June 5, 2018
Last Updated
February 5, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share